Precigen, Inc.
PGEN
$4.15
$0.071.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 281.35% | 206.93% | 16.76% | 24.69% | -1.06% |
| Total Other Revenue | -159.09% | -- | 161.54% | 187.50% | -833.33% |
| Total Revenue | 283.61% | 206.61% | 19.39% | 25.92% | -3.09% |
| Cost of Revenue | -33.58% | 8.34% | -19.60% | 2.33% | -74.13% |
| Gross Profit | 65.74% | 8.19% | 42.56% | 2,510.00% | 75.92% |
| SG&A Expenses | 60.41% | 143.91% | 56.54% | 21.75% | 7.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.63% | 68.37% | 6.29% | -6.04% | -2.80% |
| Operating Income | 4.71% | -62.17% | -5.94% | 7.43% | 2.79% |
| Income Before Tax | -18.62% | -510.63% | 55.95% | -127.85% | 40.66% |
| Income Tax Expenses | 100.00% | -- | 100.18% | -- | 73.80% |
| Earnings from Continuing Operations | -19.14% | -510.33% | 54.68% | -128.13% | 40.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.14% | -510.33% | 54.68% | -128.13% | 40.32% |
| EBIT | 4.71% | -62.17% | -5.94% | 7.43% | 2.79% |
| EBITDA | 7.01% | -63.58% | -10.23% | 3.72% | -1.38% |
| EPS Basic | 1.49% | -1,118.87% | 61.42% | -93.59% | 49.32% |
| Normalized Basic EPS | 13.54% | -448.43% | 25.39% | -93.29% | 15.19% |
| EPS Diluted | 1.49% | -1,118.87% | 61.42% | -93.59% | 49.32% |
| Normalized Diluted EPS | 13.54% | -448.43% | 25.39% | -93.29% | 15.19% |
| Average Basic Shares Outstanding | 20.86% | 11.34% | 17.46% | 17.92% | 17.77% |
| Average Diluted Shares Outstanding | 20.86% | 11.34% | 17.46% | 17.92% | 17.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |